Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study.

Romain BarusFrançois MontastrucClaire de CanecaudeHaleh BagheriAgnès SommetMaryse Lapeyre Mestre

Published in: Expert opinion on drug safety (2023)

Sublingual/buccal buprenorphine might increase the risk of reporting dental problems. However, these results do not modify the benefits of sublingual/buccal buprenorphine in the treatment of opioid use disorders.

Keyphrases

allergic rhinitis
mental health
adverse drug
oral health
emergency department
drug induced
replacement therapy